Aphthasol
Company: Block Drug CompanyApproval Status: Approved December 1997
Treatment for: canker sores
Areas: Dental / Dentistry; Immune System
| General Information | Clinical Results |
General Information
A new prescription medication is now available to dentists and physicians to provide help to millions of canker sore sufferers in the U.S. Aphthasol (amlexanox oral paste, 5%), the first and only prescription medication indicated specifically for the treatment of canker sores, has been approved in patients with normal immune systems. Aphthasol is available in 5 gram tubes.
Clinical Results
Aphthasol was proven safe and effective when used as directed in four clinical trials with more than 1,300 patients. The most common adverse effects, as reported by 1-2% of patients, were transient pain, burning, and/or stinging sensations at the site of application. Clinical data confirms that best results from Aphthasol occur with earliest possible use.
Aphthasol Drug Information
The Aphthasol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
